TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
EMPLOYEES
QIAGEN DNA Synthesis AB
Closing information (x1000 SEK)
Closing information | 2023/12 | 2022/12 | 2021/12 |
Turnover |
100,080
|
78,460
|
85,547 |
Financial expenses |
8,941
|
4,961
|
2,434 |
Earnings before taxes |
-39,609
|
-53,200
|
-32,499 |
EBITDA |
-19,815
|
-40,223
|
-22,804 |
Total assets |
168,562
|
159,529
|
142,408 |
Current assets |
86,552
|
89,847
|
74,058 |
Current liabilities |
131,698
|
140,555
|
130,234 |
Equity capital |
36,864
|
18,974
|
12,174 |
- share capital |
200
![]() |
200
![]() |
200 |
Employees (average) |
99
|
105
|
97 |
Financial ratios
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Solvency |
21.9%
|
11.9%
|
8.5% |
Turnover per employee |
1,011
|
747
|
882 |
Profit as a percentage of turnover |
-39.6%
|
-67.8%
|
-38.0% |
Return on assets (ROA) |
-18.2%
|
-30.2%
|
-21.1% |
Current ratio |
65.7%
|
63.9%
|
56.9% |
Return on equity (ROE) |
-107.4%
|
-280.4%
|
-267.0% |
Change turnover |
21,620
|
-7,087
|
-44,649 |
Change turnover % |
28%
|
-8%
|
-34% |
Chg. No. of employees |
-6
|
8
|
6 |
Chg. No. of employees % |
-6%
|
8%
|
7% |
Total value of public sale
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.